British Study: Blood precision from AstraZeneca vaccine has high mortality

Although very rare, a blood clotting syndrome after the first dose of AstraZeneca vaccine presents high risk of death and can appear in young and healthy people, according to British researchers. Data shows that in people under 50, blood clots appear in a person [...]
The data shows that in people under the age of 50, blood clotting appears in a person in every 50,000 people who took the vaccine, writes The GuardianReport Express.
Scientists examined the symptoms, signs, and results in 220 confirmed and possible cases that were presented in British hospitals between March 22nd and June 6th of this year.
It is important to say that this type of reaction to AstraZeneca and Oxford vaccine is very rare”, Dr. Sue Ward, leader of the analysis published in the magazine “The New England Journal of Medicine”.
But for those with blood clots, the results can be devastating, she added. This often affects young people, healthy people who receive the vaccine and have high mortality rates. It is especially dangerous, when the patient has low amounts of thrombocites and bleeding in the brain”, Pavor said.
Fifty percent of the cases in the analysis had not been ill in the past, and it seems that there are no individual risk factors for this syndrome, says Beverly Hunt, professor of trumpet and hemosthase at Kings College London.
Researchers found in analysis that the known syndrome with the cut V ITT left 23 percent of its students dead. The risk of death increases to 73 percent in low - level patients of thrombocites and brain bleeding after blood clots in the brain.












